Showing results (201-210 of 276) with videos related to
Sort By:
Pageof 28
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomesLucy Haggstrom, Yeh Chen Lee, Clare Scott, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 19, 2023
The KORE-INNOVATION trial, a prospective controlled multi-site clinical study to implement and assess the effects of an innovative peri-operative care pathway for patients with ovarian cancer: rationale, methods and trial designMelisa Guelhan Inci, Jalid Sehouli, Eva Schnura, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 22, 2024
How long is long enough? An international survey exploring practice variations on the recommended duration of maintenance therapy with PARP inhibitors in patients with platinum sensitive recurrent ovarian cancer and long-term outcomesLucy Haggstrom, Yeh Chen Lee, Clare Scott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian CancerJoyce F Liu, Isabelle Ray-Coquard, Frederic Selle, et al.BMC Medical Ethics|October 23, 2016
Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 studyDavid J Pulford, Philipp Harter, Anne Floquet, et al.The New England Journal of Medicine|February 28, 2019
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian NeoplasmsPhilipp Harter, Jalid Sehouli, Domenica Lorusso, et al.The Lancet. Oncology|August 31, 2024
Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGEPhilippe Morice, Giovanni Scambia, Nadeem R Abu-Rustum, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
Clinical trials in recurrent ovarian cancerMichael Friedlander, Edward Trimble, Anna Tinker, et al.The Lancet. Oncology|November 23, 2015
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trialAndreas du Bois, Gunnar Kristensen, Isabelle Ray-Coquard, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 2022
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor EntitiesNader Hirmas, Rainer Hamacher, Miriam Sraieb, et al.Pageof 28